NCT07566832 Velocity-Based Resistance Training Effects on Inflammation in Older Adults
| NCT ID | NCT07566832 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Taipei University |
| Condition | Aging |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-04-20 |
| Primary Completion | 2029-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-04-20 with a primary completion date of 2029-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to investigate the effects of resistance training (RT) with different training volumes on immune modulation and anti-inflammatory responses in older adults. Participants will be randomly assigned to one of three RT volume groups (low, medium, or high) or a non-exercise control group. Participants in the training groups will complete a 4-week RT program, followed by a 4-week detraining phase. The findings are expected to provide evidence for volume-specific RT prescriptions to support healthy aging.
Eligibility Criteria
Inclusion Criteria: * Aged 60-75 years or older * No regular resistance training habit (defined as ≥2 sessions per week) in the past year * No musculoskeletal injuries within the past six months Exclusion Criteria: * Obesity (BMI \> 30 kg/m²), diabetes, hypertension, cancer, heart, kidney, or liver disease, or any other condition that may influence study outcomes. * Regular use of anti-inflammatory medications (e.g., NSAIDs). * Smoking or alcohol abuse * Inability to safely perform the prescribed resistance exercise movements * Unable to fully comprehend the study information and instructions.
Contact & Investigator
Shun-Hsi Tsai, Ph.D.
PRINCIPAL INVESTIGATOR
National Taipei University
Frequently Asked Questions
Who can join the NCT07566832 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, up to 75 Years, studying Aging. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07566832 currently recruiting?
Yes, NCT07566832 is actively recruiting participants. Contact the research team at shunhsi@mail.ntpu.edu.tw for enrollment information.
Where is the NCT07566832 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT07566832 clinical trial?
NCT07566832 is sponsored by National Taipei University. The principal investigator is Shun-Hsi Tsai, Ph.D. at National Taipei University. The trial plans to enroll 60 participants.